Medication info
Kosartan Tablets (Losartan Potassium)

Kosartan Tablets (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Kolon Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200500581 · Notified 2005.05.04

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after the start of treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if needed. If blood pressure is not controlled with this drug alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this drug once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For patients older than 75 years, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have reduced intravascular effective blood volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Kolon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to treat hypertension. It is particularly helpful in preventing and treating kidney disease in patients with type 2 diabetes who have hypertension. Therefore, it plays an important role in controlling blood pressure and protecting kidney health.

How to take

Adult dose

This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after the start of treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if needed. If blood pressure is not controlled with this drug alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this drug once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For patients older than 75 years, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have reduced intravascular effective blood volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus, especially during the second and third trimesters, so pregnant women and women who may become pregnant should not take it. If pregnancy is confirmed, this medication should be discontinued immediately, and regular check-ups are necessary for the health of the fetus and newborn. Patients who are hypersensitive to this medication, those with severely impaired liver function, hereditary angioedema, primary hyperaldosteronism, etc., should not take this medication. Elderly patients, those with hyperkalemia, liver impairment, heart valve disease, cardiovascular disease, or weak kidney function should use this medication cautiously. This medication is generally safe but may cause side effects such as dizziness, muscle cramps, cough, and indigestion, so patients should inform their doctor of any abnormal symptoms. Regular monitoring of blood pressure and kidney function is necessary, as blood pressure may drop too low or kidney function may worsen. Caution is advised when taking with potassium-rich medications or supplements, as serum potassium levels can increase to dangerous levels. Consultation with healthcare professionals is required when taking this medication alongside non-steroidal anti-inflammatory drugs (NSAIDs), as it may reduce blood pressure control and worsen kidney function. Pregnant or breastfeeding women should avoid taking this medication, especially if breastfeeding, it is recommended to stop breastfeeding. This medication should not be administered to children under 6 years of age or to pediatric and adolescent patients with severely impaired kidney function. Dizziness may occur while driving or operating machinery during the use of this medication; caution is advised. Overdosage may lead to hypotension and bradycardia, requiring immediate medical attention for appropriate treatment. This medication should be kept out of reach of children and not transferred to another container to maintain its quality.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 128 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • diminished libido
  • memory impairment
  • migraine
  • neurosensitivity
  • dysesthesia
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • thoracic discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • diaphoresis
  • urticaria
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision loss
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylactoid syndrome
  • hepatic dysfunction
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • myalgia
  • weakness
  • increased creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythema multiforme
  • hyperkalemia
  • hyponatremia
  • increased ALT
  • increased serum creatinine
  • decreased hemoglobin and hematocrit
  • increased liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular extrasystole
  • arrhythmia
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is also advisable to store it in a cool and dry place at a temperature between 15°C and 30°C.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.